Real-world effectiveness and healthcare utilization of nivolumab for advanced head and neck cancer: a real-world population-based descriptive study
Dai WF, Nguyen L, Liu N, Chan KK. Oral Oncol. 2026; 173:107851. Epub 2026 Jan 8.
Publications
Comparative analysis of radiation exposure from CT scan and VQ scan in the diagnosis of pulmonary embolism: an early-onset cancer risk assessment
Simard C, Siegal DM, Nguyen L, Le Gal G, Sutradhar R, Delluc A. J Thromb Haemost. 2025; S1538-7836(25): 00894-3. Epub 2025 Dec 12.
Palliative care involvement and intensity of end-of-life care among adolescents and young adults with cancer: a population-based study
Abdelaal M, Parsons H, Srikanthan A, Al-Awamer A, Mosher PJ, Lapenskie J, Cleyn S, Fung SG, Yoo S, Dhaliwal S, Tanuseputro P, Downar J. CMAJ. 2025; 197(41): E1363-E1373.
Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study
Salter B, Garcia-Horton A, Walker I, Leber B, Lepic K, Mian H, Gayowsky A, Pond GR, Seow H, Berg T. Blood Cancer J. 2025; 15(1): 204.
Thyroid cancer treatment among adolescents and young adult women and reproductive outcomes: a population-based cohort study
Imsirovic H, Richardson H, Shellenberger J, Velez MP. Hum Reprod Open. 2025; 2025(4): hoaf070.
A population-based matched cohort study of extra-digestive cancer incidence and mortality in individuals with and without inflammatory bowel disease
Murthy SK, Ahmed F, Pugliese M, Taljaard M, Tandon P, Matthews P, Kaplan GG, Coward S, Bernstein CN, Benchimol EI, Kuenzig ME, Targownik LE, Singh H; Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC). Aliment Pharmacol Ther. 2025; Nov 11 [Epub ahead of print].
Development and validation of EsoTIME, a prognostication tool for resected esophageal and gastroesophageal cancer
Harrison LD, Gupta V, Yuen M, Coburn NG, Pugliese M, Ekuma O, Derksen S, Compton C, Boyes R, Davis L, Decker K, Kidane B, Ringash J, Hsu AT, Mahar A; Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO) Group. Ann Surg Oncol. 2026; 33(2):955-966. Epub 2025 Oct 25.
Physician payment models and preventive cancer screening: a population-based retrospective cohort analysis from Ontario, Canada
Bai Y, Devlin RA, Habbous S, Jaakkimainen L, Sarma S. Fam Pract. 2025; 42(6):cmaf076.
Pembrolizumab vs. chemotherapy in the first-line setting of PD-L1 ≥ 50% metastatic non-small cell lung cancer: a real-world cost-effectiveness analysis
Liu B, Parmar A, Luo J, Dai WF, Chan KKW. Eur J Health Econ. 2025; Oct 8 [Epub ahead of print].
Contemporary incidence and survival of lung neuroendocrine neoplasms
Hallet J, Rousseau M, Wakeam E, Myrehaug S, Meloche-Dumas L, Gombay A, Chan W, Singh S. JAMA Netw Open. 2025; 8(10):e2535125.